MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Complanatoside A

CAS No. : 146501-37-3

MCE 站：Complanatoside A

产品活性：Complanatoside A是从黄芪分离的黄酮醇糖苷，目前它被用作2010版中国药典 A. complanatus 的质量控制指数。

研究领域：Others

作用靶点：Others

In Vitro: A simple and sensitive LC-MS/MS method is developed for the determination of complanatoside A in rat plasma over the range of 2.3–575 ng/mL. Complanatoside A is extracted from plasma by a protein precipitation procedure, separated by LC and detected by MS/MS in positive electrospray ionization mode. The lower limit of quantification is established at 2.3 ng/mL. Intra- and inter-day precisions (LLOQ, low-QC, med-QC and high-QC) are less than 7.9%, and accuracies are between 94.0 and 105.1%. Matrix effect is acceptable (97.9–103.0%) and extraction recovery is reproducible (88.5–94.4%). Complanatoside A is stable in the investigated conditions. The method is applied to the pharmacokinetics of complanatoside A in rats.

相关产品：PEG300  |  SBE-β-CD  |  Corn oil  |  Tween 80  |  D-Lin-MC3-DMA  |  Polyethylene glycol 12-hydroxystearate  |  Lipopolysaccharides  |  JC-1  |  (2-Hydroxypropyl)-β-cyclodextrin  |  Digitonin  |  Methyl-β-cyclodextrin  |  5-Ph-IAA  |  CFSE  |  Tocofersolan  |  Biotin  |  O-Propargyl-Puromycin  |  Yoda 1  |  3X FLAG peptide TFA  |  DTT  |  GsMTx4 TFA  |  Monocrotaline  |  Cremophor EL  |  Thiazolyl Blue  |  FLAG peptide  |  IPTG  |  Nile Red  |  Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)  |  D-Luciferin potassium  |  Phosal 50 PG

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。